Chemoinformaics analysis of 12-Hydroxyamoorastatone
| Molecular Weight | 532.586 | nRot | 2 |
| Heavy Atom Molecular Weight | 496.298 | nRig | 32 |
| Exact Molecular Weight | 532.231 | nRing | 6 |
| Solubility: LogS | -4.116 | nHRing | 2 |
| Solubility: LogP | 0.63 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 5 |
| nHA | 10 | APOL | 78.7845 |
| nHD | 4 | BPOL | 43.9275 |
| QED | 0.403 |
| Synth | 6.463 |
| Natural Product Likeliness | 3.142 |
| NR-PPAR-gamma | 0.503 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.997 |
| HIA | 0.702 |
| CACO-2 | -5.299 |
| MDCK | 0.000106227 |
| BBB | 0.556 |
| PPB | 0.432345 |
| VDSS | 1.002 |
| FU | 0.480144 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.087 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.289 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.059 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.052 |
| CYP3a4-sub | 0.21 |
| CL | 3.739 |
| T12 | 0.102 |
| hERG | 0.005 |
| Ames | 0.059 |
| ROA | 0.936 |
| SkinSen | 0.011 |
| Carcinogencity | 0.073 |
| EI | 0.016 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.823008 |